Dr. Suniti Solomon detected India’s first cases of HIV. She also founded YRG CARE & raised CIDI Co-director Dr. Sunil Solomon. Learn about her commitment to science & unwavering dedication to compassionate patient care.
World TB Day event in Pune includes a special street play, counseling sessions, and research and education discussions, aimed to engage the community in healthy approaches to TB treatment and prevention under this year’s World TB Day theme "Yes we can end TB."
TAG’s 2022 Research in Action Awards will honor activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C around the world. Check it out to see Amita Gupta, GKII Co-Chair, receive her award.
In a press release issued Tuesday, December 7, the U.S. Centers for Disease Control and Prevention (CDC) announced the launch of two global networks to address the rise of antimicrobial resistance and other healthcare threats.
Dr. Akshay Gupte and colleagues discovered that elevated IL-6 can predict poor treatment outcomes, showcasing a need for including IL-6 in clinical screenings.
Gauri Dhumal and Neetal Nevrekar received the award from USAID’s Women in Science Mentoring Program for separate pilot projects that study better tuberculosis treatment methods. Nishi Suryavanshi is their mentor.
Reporting from the virtual 51st Union Conference on Lung Health, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) announced promising findings from 2 TB trials
Join Dr. Jennifer Nuzzo for a conversation with Drs. Brian Wahl and Sanjay Mehendale on what we can learn from India about pandemic safety. Register now!
For decades, global health systems have been transitioning from paper to electronic health records to improve patient data accessibility, particularly to facilitate epidemiological study and preventive care.
The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes.
The launch of the study coincides with the World TB week. “Titled `PraGaTHi’, this study will explore how the changes in immunity due to pregnancy and GDM increase the risk of TB in pregnant and postpartum women.”
Sunil Solomon: “Each of us brings a different skill set... The coalition is focused on translating what all of us find for clinical relevance to make sure that whatever we are doing is tailored toward improving the public’s health.”
Dr. Amita Gupta spoke to the Hindustan Times about the monkeypox outbreak. “Currently mass vaccination is not required. Instead, priority is recommended for contacts of cases..."
Fogarty International Center: Dr. Matt Robinson: "So sometimes you provide treatment for the worst possible scenario,” like prescribing antibiotics before identifying the cause of illness.
Last week, the Centers for Disease Control and Prevention (CDC) confirmed that at least four people in Michigan, US, were infected with a version of the coronavirus observed mostly in minks during the first year of the pandemic.
PDF: Dr. Gauri Dhumal was interviewed for the Weill Cornell Medicine Center for Global Health's Female Global Scholars newsletter. It is part of the Women In Global Health Research Initiative.
The new vaccines may chip away at the number of Americans who have refused to be vaccinated up to this point, but their biggest value is likely to be global.
inHealth Precision Medicine Society at Johns Hopkins
Zeger and Robinson’s group developed and validated SCARP using data from electronic health records of COVID-19 patients in five Hopkins-associated hospitals.
Dr. Bollinger: "It is important to remember that any population health effort to address SDOH must also take into account racial discrimination—in society in general as well as in health care."
Dr. Bollinger: “My own expectation is that being fully vaccinated, including boosters, will still provide a reduced risk of hospitalization and death."
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...
To address the global burden of TB, an international collaboration led by Johns Hopkins Medicine has today been awarded up to $200 million in research funding over five years by USAID for the SMART4TB project.
Researchers at Johns Hopkins Medicine learned that they now have an enhanced opportunity to help move the world toward a day when that observance is rendered obsolete.
Johns Hopkins News Release: Dr. Suryavanshi discusses her study on mobile health and technology training for improving care among HIV+ pregnant and post-partum women and their babies
NIH Press Release : NIH announces a large international clinical trial to prevent multidrug-resistant TB in children, adolescents, and adults who live with someone who has MDR-TB. CCGHE's Dr. Amita Gupta is a protocol chair.
Newswise — Amita Gupta, M.D., deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University School of Medicine, will present a multicounty study of preventive treatment for tuberculosis (TB) in HIV-infected pregnant and postpartum women—...
The Maryland-based health care informatics company CTIS and its founders, Raj and Bharti Shah, have collaborated with the Johns Hopkins Center for Clinical Global Health Education and Byramjee Jeejeebhoy Government Medical College to equip and dispatch a custom-designed mobile health care services...
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS...
